Navigation Links
Thomson Reuters Launches New Biomarkers Solution
Date:6/17/2008

BIOMARKERcenter is First Comprehensive and Quality Assured Biomarker

Solution Available to the Pharmaceutical Industry

PHILADELPHIA and LONDON, June 17 /PRNewswire-FirstCall/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, announced today the launch of BIOMARKERcenter, a unique comprehensive resource for biomarker intelligence. This new solution will be the first to provide the pharmaceutical industry with a framework for assessing the potential of a biomarker and to be alerted of any changes in their status.

BIOMARKERcenter covers the biomarkers identified in literature, patents, conferences, clinical trial information, and other sources for all major therapeutic areas: oncology, cardiovascular diseases, diabetes, respiratory disorders, autoimmune diseases and neurological disorders. For each therapy area, it includes not only biomarkers with established clinical usage, but also emerging uses for the biomarker. Each record has been manually created by a team of Thomson Reuters experts and provides a unique report on the biomarker using a novel lifecycle model. Other data provided will include the name, classification, biological entities/processes involved, associated drugs, role or utilities, measurement techniques, regulatory status and related diagnostic kits.

Biomarkers are measurable indicators which can be used to define a biological state. Using Biomarkers as part of a pharmaceutical R&D program can increase the success of the project by encouraging innovation, improving efficiency, saving costs and delivering a valuable advantage over competitors.

"BIOMARKERcenter is the first reliable and comprehensive database of biomarkers available to the pharmaceutical and diagnostic industries. It sets a new standard for the presentation and analysis of Biomarker information," said Jon Brett-Harris, EVP Pharmaceutical and Chemicals Markets, Thomson Reuters. "B
'/>"/>

SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Thomson Scientific Begins Expansion of Web of Science
2. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
3. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
4. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
5. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
6. Cardiac Science Launches Anywhere Data Management for HIS and EMR Systems
7. Cardium Launches New AWARE Clinical Study Website
8. WellCentive Launches New Secure Messaging Platform for Its Patient Registry System
9. ChanTest Launches Redesigned Web Site
10. Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
11. SAFC Hitech Launches Metalorganic Bulk Vapor Distribution System for Compound Semiconductor Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... JourneyLite of Houston, LLC announced today that it ... surgical option, vertical sleeve gastrectomy , along with ... The first sleeve gastrectomy procedure at the facility was ... on October 20, 2009. The patient is reported ...
(Date:12/3/2009)... SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: ... development of compounds for the treatment of cardiovascular and ... last patient visit in its Phase 2 FDG-PET clinical ... 52 patients and was carried out at five sites ...
(Date:12/3/2009)... Inverness Medical Innovations, Inc. (NYSE: IMA ), a ... health at home through the merger of rapid diagnostics and ... on its Series B Convertible Perpetual Preferred Stock ( IMA-PB). ... stock in an amount per share equal to the quotient ...
(Date:12/2/2009)... Biosciences Corporation (Nasdaq: MATK ) announced today that it ... fiscal year 2009 on December 16, 2009, at approximately 4:00 ... p.m. ET Martek will conduct a conference call to discuss ... to the call live via webcast by visiting Martek,s web ...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2
... promising new technique has been developed that will ... imaging of new cells injected into the body, ... The new technique, which involves engineering antibody fragments ... cells of interest for PET imaging purposescould significantly ...
... The Ensign,Group, Inc. (Nasdaq: ENSG ), the parent ... services and assisted living,companies, announced today that its Board ... per share of Ensign common stock, payable,on or before ... June 30, 2008.,Ensign has been a dividend-paying company since ...
... Line, PARSIPPANY, N.J., June 16 ... on nephrology and endocrinology,announced today that it ... ROCALTROL is a vitamin D analog prescribed ... resultant,metabolic bone disease in patients with moderate ...
Other Biology Technology:New molecular imaging techniques may lead to advances in disease treatment 2The Ensign Group Declares Quarterly Dividend 2Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc. 2
(Date:12/4/2009)... total gene activity in organs relevant for coronary artery ... Institutet have identified a module of genes that is ... the atherosclerotic plaque. The findings, which are to be ... suggest that targeting the migration of white blood cells ...
(Date:12/4/2009)... accepted thinking about amyloids the fibrous protein deposits associated ... open up a potential new area for therapeutics. , It ... of proteins sometimes known as fibres - are inert, but ... can damage cells and cause disease. , But in ...
(Date:12/3/2009)... windows or solar panels that repels grime and dirt? ... New Tel Aviv University research, just published in ... at the nano-scale level that could make these futuristic ... Operating in the range of 100 nanometers (roughly one-billionth ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2New therapy targets for amyloid disease 2A window that washes itself? 2Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine 58319 1Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine 58319 2Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 1Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 2AFOSRs basic research may lead to revolutionary new devices 10102 1AFOSRs basic research may lead to revolutionary new devices 10102 2
... A University of Michigan research team has found that introducing ... therapy helped generate bone around dental implants, according to a ... Therapy. , In a patient with a sizeable mouth wound, ... one---the patient also needs the bone structure to anchor the ...
... prevailing belief that the HIV epidemic in the UK can ... that HIV spread via at least six independent virus introductions ... issue of the Proceedings of the National Academy of Sciences, ... impact on the growth of the epidemic and that changes ...
... in the passing of genetic material from a parent ... by a team of Berkeley researchers. Their study may ... recognize and stay attached to microtubules, hollow fibers in ... the faithful segregation of chromosomes during cell division. , ...
Other Biology News:Gene therapy promising for growing tooth-supporting bone 2Gene therapy promising for growing tooth-supporting bone 3HIV-1 spread through six transmission lines in the UK 2HIV-1 spread through six transmission lines in the UK 3Key mechanism in genetic inheritance during cell division identified 2Key mechanism in genetic inheritance during cell division identified 3
Anti-Dardarin Immunogen: Synthetic peptide from rat LRRK2. Available Date: 38814...
... to MSY2/YBOX2 ( Abpromise for ... Antigen: Synthetic peptide derived from ... of Human MSY2/YBOX2. (Note: the ... (Peptide available as ...
Request Info...
Molecular Biology grade. Ideally suited for DNA and RNA separation and recovery. High gel strength. Gelling temp. 36C. Melting temp. 88C. EEO: 0.05-0.13 Resolution 0.2-40 kb; Rnase/Dnase: none detec...
Biology Products: